139 related articles for article (PubMed ID: 24158013)
21. Quinazoline-based multi-tyrosine kinase inhibitors: synthesis, modeling, antitumor and antiangiogenic properties.
Conconi MT; Marzaro G; Urbani L; Zanusso I; Di Liddo R; Castagliuolo I; Brun P; Tonus F; Ferrarese A; Guiotto A; Chilin A
Eur J Med Chem; 2013 Sep; 67():373-83. PubMed ID: 23900004
[TBL] [Abstract][Full Text] [Related]
22. One-pot synthesis and cytotoxicity studies of new Mannich base derivatives of polyether antibiotic--lasalocid acid.
Huczyński A; Rutkowski J; Borowicz I; Wietrzyk J; Maj E; Brzezinski B
Bioorg Med Chem Lett; 2013 Sep; 23(18):5053-6. PubMed ID: 23932361
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and antiproliferative activity of 4-substituted-piperazine-1-carbodithioate derivatives of 2,4-diaminoquinazoline.
Cao SL; Han Y; Yuan CZ; Wang Y; Xiahou ZK; Liao J; Gao RT; Mao BB; Zhao BL; Li ZF; Xu X
Eur J Med Chem; 2013 Jun; 64():401-9. PubMed ID: 23665106
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and antiproliferative evaluation of piperazine-1-carbothiohydrazide derivatives of indolin-2-one.
Lin HH; Wu WY; Cao SL; Liao J; Ma L; Gao M; Li ZF; Xu X
Bioorg Med Chem Lett; 2013 Jun; 23(11):3304-7. PubMed ID: 23602441
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and evaluation of (Z)-2,3-diphenylacrylonitrile analogs as anti-cancer and anti-microbial agents.
Alam MS; Nam YJ; Lee DU
Eur J Med Chem; 2013 Nov; 69():790-7. PubMed ID: 24113364
[TBL] [Abstract][Full Text] [Related]
26. Preparation of a series of novel bichalcones linked with a 1,4-dimethylenepiperazine moiety and examination of their cytotoxicity.
Reddy MV; Chen SS; Lin ML; Chan HH; Kuo PC; Wu TS
Chem Pharm Bull (Tokyo); 2011; 59(12):1549-54. PubMed ID: 22130379
[TBL] [Abstract][Full Text] [Related]
27. New palbociclib analogues modified at the terminal piperazine ring and their anticancer activities.
Wang P; Huang J; Wang K; Gu Y
Eur J Med Chem; 2016 Oct; 122():546-556. PubMed ID: 27448913
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis, and anti-tumor activities of novel Brevinin-1BYa peptidomimetics.
Xiong S; Wang N; Liu C; Shen H; Qu Z; Zhu L; Bai X; Hu HG; Cong W; Zhao L
Bioorg Med Chem Lett; 2021 Apr; 37():127831. PubMed ID: 33556573
[TBL] [Abstract][Full Text] [Related]
29. Syntheses of novel β-carboline derivatives and the activities against five tumor-cell lines.
Bai B; Li XY; Liu L; Li Y; Zhu HJ
Bioorg Med Chem Lett; 2014 Jan; 24(1):96-8. PubMed ID: 24345445
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of 1-naphtylpiperazine derivatives as serotoninergic ligands and their evaluation as antiproliferative agents.
Fiorino F; Magli E; Perissutti E; Severino B; Frecentese F; Esposito A; De Angelis F; Incisivo GM; Massarelli P; Nencini C; Di Gennaro E; Budillon A; Di Cintio A; Santagada V; Caliendo G
Eur J Med Chem; 2011 Jun; 46(6):2206-16. PubMed ID: 21440338
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis and antitumour activity of bisquinoline derivatives connected by 4-oxy-3-fluoroaniline moiety.
Li S; Huang Q; Liu Y; Zhang X; Liu S; He C; Gong P
Eur J Med Chem; 2013 Jun; 64():62-73. PubMed ID: 23644189
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and antiproliferative activity of benzofuran-based analogs of cercosporamide against non-small cell lung cancer cell lines.
Bazin MA; Bodero L; Tomasoni C; Rousseau B; Roussakis C; Marchand P
Eur J Med Chem; 2013 Nov; 69():823-32. PubMed ID: 24121233
[TBL] [Abstract][Full Text] [Related]
33. Quinazoline-sulfonamides as potential antitumor agents: synthesis and biological testing.
Alafeefy AM; Alqasoumi SI; Ashour AE; Alshebly MM
J Enzyme Inhib Med Chem; 2013 Apr; 28(2):375-83. PubMed ID: 22468752
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and antiproliferative activity of sulfonamide-based peptidomimetic calpain inhibitors.
Donkor IO; Xu J; Liu J; Cameron K
Bioorg Med Chem; 2020 May; 28(9):115433. PubMed ID: 32199690
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the effects of PAR1 antagonists, PAR4 antagonists, and their combinations on thrombin-induced human platelet activation.
Wu CC; Teng CM
Eur J Pharmacol; 2006 Sep; 546(1-3):142-7. PubMed ID: 16890935
[TBL] [Abstract][Full Text] [Related]
36. Novel organic proteasome inhibitors identified by virtual and in vitro screening.
Basse N; Montes M; Maréchal X; Qin L; Bouvier-Durand M; Genin E; Vidal J; Villoutreix BO; Reboud-Ravaux M
J Med Chem; 2010 Jan; 53(1):509-13. PubMed ID: 19919035
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological evaluation of novel spin labeled 18β-glycyrrhetinic acid derivatives.
Liu Y; Qian K; Wang CY; Chen CH; Yang X; Lee KH
Bioorg Med Chem Lett; 2012 Dec; 22(24):7530-3. PubMed ID: 23122524
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, anticancer activity and pharmacokinetic analysis of 1-[(substituted 2-alkoxyquinoxalin-3-yl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives.
Lee YB; Gong YD; Kim DJ; Ahn CH; Kong JY; Kang NS
Bioorg Med Chem; 2012 Feb; 20(3):1303-9. PubMed ID: 22226981
[TBL] [Abstract][Full Text] [Related]
39. Peptidomimetics Based On Dehydroepiandrosterone Scaffold: Synthesis, Antiproliferation Activity, Structure-Activity Relationship, and Mechanisms.
Wang X; Su H; Wang W; Chen C; Cao X
Sci Rep; 2016 Sep; 6():32654. PubMed ID: 27585479
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of novel α-santonin derivatives as potential cytotoxic agents.
Arantes FF; Barbosa LC; Maltha CR; Demuner AJ; Marçal da Costa P; Ferreira JR; Costa-Lotufo LV; Moraes MO; Pessoa C
Eur J Med Chem; 2010 Dec; 45(12):6045-51. PubMed ID: 20971532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
